Gensight Biologics S.a annual operating margin
2020
2021
2022
2023
2024
2025
Gensight Biologics S.a Operating Margin Growth & History (SIGHT)
Gensight Biologics S.a's operating margin was −1,105,500.00% for fiscal 2025.
View full Gensight Biologics S.a company overviewGensight Biologics S.a annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,105,500.00% | −1104445.80 pp |
| 2024 | 2024-12-31 | −1,054.20% | +1289.60 pp |
| 2023 | 2023-12-31 | −2,343.80% | −1265.76 pp |
| 2022 | 2022-12-31 | −1,078.04% | −544.95 pp |
| 2021 | 2021-12-31 | −533.09% | +34.36 pp |
| 2020 | 2020-12-31 | −567.46% | — |
Gensight Biologics S.a operating margin trends
Over the last five fiscal years, Gensight Biologics S.a's operating margin decreased from −567.46% to −1,105,500.00%, a change of −1104932.54 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gensight Biologics S.a source filings ↗Community posts
GenSight advances LUMEVOQ manufacturing transfer to Catalent
GenSight ($SIGHT) said an engineering batch of GS010/LUMEVOQ at Catalent was produced as planned, with viral genome concentration meeting target specifications. Preparations have begun for a GMP-standard batch to supply special-access progr ...